Michael Toscani

516 total citations
44 papers, 368 citations indexed

About

Michael Toscani is a scholar working on Economics and Econometrics, General Health Professions and Epidemiology. According to data from OpenAlex, Michael Toscani has authored 44 papers receiving a total of 368 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Economics and Econometrics, 5 papers in General Health Professions and 5 papers in Epidemiology. Recurrent topics in Michael Toscani's work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Pharmaceutical Economics and Policy (6 papers) and Pharmaceutical industry and healthcare (4 papers). Michael Toscani is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (8 papers), Pharmaceutical Economics and Policy (6 papers) and Pharmaceutical industry and healthcare (4 papers). Michael Toscani collaborates with scholars based in United States, Italy and United Kingdom. Michael Toscani's co-authors include John L. Colaizzi, Doreen Matsui, Michael Rieder, Mary Lu Angelilli, Michael V. Vitiello, Thomas Roth, Phyllis Zee, Steven M. Albert, Marc A. Riedl and Joseph A. Barone and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Infectious Diseases.

In The Last Decade

Michael Toscani

41 papers receiving 346 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Toscani United States 9 59 56 54 53 51 44 368
Manuel Enrique Machado‐Duque Colombia 13 39 0.7× 73 1.3× 61 1.1× 70 1.3× 62 1.2× 96 548
Rosa Camila Lucchetta Brazil 12 38 0.6× 88 1.6× 43 0.8× 27 0.5× 40 0.8× 54 426
Jayashri Sankaranarayanan United States 14 41 0.7× 47 0.8× 80 1.5× 56 1.1× 56 1.1× 27 510
Willem Jan van der Veen Netherlands 14 57 1.0× 33 0.6× 41 0.8× 63 1.2× 95 1.9× 28 359
Kristin M. Richards United States 14 117 2.0× 42 0.8× 145 2.7× 44 0.8× 90 1.8× 42 691
Elizabeth R. Stevens United States 12 46 0.8× 26 0.5× 61 1.1× 94 1.8× 61 1.2× 57 473
Minjee Lee United States 14 38 0.6× 19 0.3× 112 2.1× 97 1.8× 81 1.6× 73 587
Mathieu Verbrugghe Belgium 10 112 1.9× 100 1.8× 22 0.4× 118 2.2× 43 0.8× 23 535
Grenville Rose Australia 14 19 0.3× 99 1.8× 57 1.1× 112 2.1× 28 0.5× 31 562
Noraida Mohamed Shah Malaysia 13 186 3.2× 87 1.6× 35 0.6× 52 1.0× 46 0.9× 62 631

Countries citing papers authored by Michael Toscani

Since Specialization
Citations

This map shows the geographic impact of Michael Toscani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Toscani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Toscani more than expected).

Fields of papers citing papers by Michael Toscani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Toscani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Toscani. The network helps show where Michael Toscani may publish in the future.

Co-authorship network of co-authors of Michael Toscani

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Toscani. A scholar is included among the top collaborators of Michael Toscani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Toscani. Michael Toscani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Jonathan, et al.. (2023). Evaluation of temperature excursions from USP <659> recommendations during mail transit. Journal of the American Pharmacists Association. 63(3). 847–852.
2.
Cosler, Leon E., et al.. (2022). Opioid abuse risk among student pharmacists. Journal of Opioid Management. 18(2). 161–166. 1 indexed citations
3.
Toscani, Michael, et al.. (2022). Age Demographics of Subjects Enrolled in Global, Interventional Phase 3 Melanoma Clinical Trials. Therapeutic Innovation & Regulatory Science. 56(2). 184–190. 8 indexed citations
4.
Toscani, Michael, et al.. (2022). Market Selection for MyoTecSci: How to Decide “Where to Play” from Multiple Options. Journal of Commercial Biotechnology. 27(1). 4 indexed citations
5.
Bridgeman, Mary Barna, Michael Toscani, Racquel E. Kohler, et al.. (2021). Pharmacists’ Perceptions and Drivers of Immunization Practices for COVID-19 Vaccines: Results of a Nationwide Survey Prior to COVID-19 Vaccine Emergency Use Authorization. SHILAP Revista de lepidopterología. 9(3). 131–131. 9 indexed citations
6.
Wilson, Grant Alexander, et al.. (2021). Using Lean Startup to Discover Customers in the mHealth Industry: Current Landscape and Challenges. Journal of Commercial Biotechnology. 26(3). 7 indexed citations
7.
Rametta, Mark, et al.. (2020). Sentiment of Media Coverage and Reputation of the Pharmaceutical Industry. Therapeutic Innovation & Regulatory Science. 54(1). 220–225. 1 indexed citations
8.
Toscani, Michael, et al.. (2020). Opinions and Trends of Healthcare Providers Concerning Scientific/Standard Response Documents. Therapeutic Innovation & Regulatory Science. 54(6). 1388–1397. 1 indexed citations
9.
Toscani, Michael, et al.. (2019). Shared Decision Making in Cancer Treatment: Findings from a Large Survey of Lymphoma (LYM) Patients and Survivors. Blood. 134(Supplement_1). 2134–2134. 1 indexed citations
10.
Hogan, Michael, et al.. (2017). Antimicrobial stewardship programs: Effects on clinical and economic outcomes and future directions. 24(7). 309–318. 4 indexed citations
11.
Shah, Khushbu, et al.. (2016). The PharmD/MD Dual-Degree Program and Its Potential Value in the Pharmaceutical Industry. Therapeutic Innovation & Regulatory Science. 50(6). 839–845. 2 indexed citations
12.
Stuart, Jeffrey N., et al.. (2015). Current Trends in Personalized Medicine and Companion Diagnostics: A Summary From the DIA Meeting on Personalized Medicine and Companion Diagnostics. Therapeutic Innovation & Regulatory Science. 49(4). 530–543. 5 indexed citations
13.
Gross, H.J., et al.. (2015). Sex Differences In over-the-counter sleep aid use in older adults. Value in Health. 18(3). A286–A287. 3 indexed citations
14.
Jackson, W.G., et al.. (2014). Analysis of Social Media Interactions Between Pharmaceutical Companies and Consumers: The Power of the “Like”. Therapeutic Innovation & Regulatory Science. 49(3). 387–391. 3 indexed citations
15.
Toscani, Michael, et al.. (2011). PHP15 ISSUES ASSOCIATED WITH BIOLOGIC AGENTS: HEALTHCARE STAKEHOLDER SURVEY. Value in Health. 14(3). A14–A14. 2 indexed citations
16.
Suh, Dong‐Churl, et al.. (2002). Application of pharmacoeconomics to formulary decision making in managed care organizations.. PubMed. 8(2). 161–9. 14 indexed citations
17.
Toscani, Michael, John O’Connor, & David B. Nash. (2001). A Decentralized, Patient-Centered Approach to Diabetes Disease Management in the Primary Care Setting. Disease Management. 4(4). 163–171. 2 indexed citations
18.
Deverka, Patricia A., et al.. (2000). Identification of resource use and associated costs for viral meningitis.. PubMed. 9(1). 41–6. 5 indexed citations
19.
Deverka, Patricia A., et al.. (2000). Estimating the Economic Impact of Viral Meningitis in the United States. 17(6). 417–427. 4 indexed citations
20.
Angelilli, Mary Lu, Michael Toscani, Doreen Matsui, & Michael Rieder. (2000). Palatability of Oral Antibiotics Among Children in an Urban Primary Care Center. Archives of Pediatrics and Adolescent Medicine. 154(3). 267–267. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Manuel Enrique Machado‐Duque Breakdown of academic impact, for papers by Rosa Camila Lucchetta Breakdown of academic impact, for papers by Jayashri Sankaranarayanan Breakdown of academic impact, for papers by Willem Jan van der Veen Breakdown of academic impact, for papers by Kristin M. Richards Breakdown of academic impact, for papers by Elizabeth R. Stevens Breakdown of academic impact, for papers by Minjee Lee Breakdown of academic impact, for papers by Mathieu Verbrugghe Breakdown of academic impact, for papers by Grenville Rose Breakdown of academic impact, for papers by Noraida Mohamed Shah
Rankless by CCL
2026